Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected pediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk: Meta-analysis of vancomycin trough in children.

[1]  D. Levine,et al.  Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Socie , 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[2]  K. Sridharan,et al.  Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital , 2019, Pediatric Drugs.

[3]  H. Mikamo,et al.  Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[4]  K. Matson,et al.  Nephrotoxicity With Vancomycin in the Pediatric Population: A Systematic Review and Meta-Analysis , 2017, The Pediatric infectious disease journal.

[5]  J. Vallejo,et al.  The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection , 2017, The Pediatric infectious disease journal.

[6]  E. Heil,et al.  Vancomycin AUC/MIC and Corresponding Troughs in a Pediatric Population. , 2017, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

[7]  H. Mikamo,et al.  Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[8]  M. Malloy,et al.  The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit , 2017, BMC Pediatrics.

[9]  D. Cheng,et al.  Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram‐positive infection , 2016, Journal of clinical pharmacy and therapeutics.

[10]  Jina Lee,et al.  Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children , 2016, Journal of Korean medical science.

[11]  J. Vallejo,et al.  Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome , 2016, The Pediatric infectious disease journal.

[12]  E. Capparelli,et al.  Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children. , 2015, Journal of the Pediatric Infectious Diseases Society.

[13]  Yun Fang,et al.  High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis , 2015, Journal of chemotherapy.

[14]  H. Maples,et al.  Balancing Vancomycin Efficacy and Nephrotoxicity: Should We Be Aiming for Trough or AUC/MIC? , 2015, Pediatric Drugs.

[15]  K. V. Van Meurs,et al.  Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in Neonates , 2014, Antimicrobial Agents and Chemotherapy.

[16]  A. Ragab,et al.  Incidence and Predisposing Factors of Vancomycin-Induced Nephrotoxicity in Children , 2013, Infectious Diseases and Therapy.

[17]  Marlea G. Wellein,et al.  Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial , 2011, Antimicrobial Agents and Chemotherapy.

[18]  D. Levine,et al.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Susan M Abdel-Rahman,et al.  Developmental pharmacology--drug disposition, action, and therapy in infants and children. , 2003, The New England journal of medicine.